IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial ...Middle East

SOUTH SAN FRANCISCO, Calif., March 22, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events and provided...

Hence then, the article about ideaya biosciences upcoming investor relations events and updated darovasertib topline results guidance from phase 2 3 optimum 02 trial was published today ( Sunday 22/03/2026 - 05:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial )

Also on site :

• Today's Famous Celebrity Birthdays for March 22, 2026: Reese Witherspoon, William Shatner
• Firefighters rush to Morrisons convenience store in Oswestry after report of fire
• Iranian Revolutionary Guard: 200 Killed and Wounded Among Zionist Enemy in 73rd Wave